Research Overviewdance therapy

Dance Movement Therapy and Mental Health: A Review of the Research

The research on dance movement therapy spans a wide range of mental health conditions. This review summarises what the evidence shows, its quality, and what responsible conclusions can be drawn.

By Gyfts Editorial Team 28 January 2026

Reviewed by Dr. Ava Gardner · Integrative Medicine Researcher13 March 2026Emerging evidence

Dance Movement Therapy and Mental Health: A Review of the Research — holistic health

Photo by RDNE Stock project on Unsplash

Quick answer

DMT research covers depression, anxiety, schizophrenia, dementia, PTSD, eating disorders, and cancer care. A 2019 meta-analysis found significant positive effects on depression, anxiety, and quality of life. Evidence quality is generally low-moderate due to small samples and methodological limitations. The Cochrane review for depression found moderate evidence of benefit as an adjunct to standard care.

Key Takeaways

•A 2019 meta-analysis of 41 studies found significant DMT effects on depression, anxiety, and quality of life
•The Cochrane review found moderate evidence for DMT as an adjunct treatment for depression
•Evidence also exists for DMT in dementia, schizophrenia, and cancer care
•Overall evidence quality is low to moderate due to small samples and methodological challenges
•DMT is a regulated profession in the UK — practitioners hold postgraduate qualifications
•Larger, more rigorous trials are needed before DMT can be recommended as a primary clinical treatment

The Research Landscape

Dance movement therapy research has grown substantially over the past two decades, though it remains a smaller evidence base than that for verbal psychotherapies. Research spans a wide range of conditions and settings, reflecting the diverse contexts in which DMT is practised — psychiatric hospitals, community mental health, oncology, neurology, education, and palliative care.

The 2019 Meta-Analysis

The most comprehensive synthesis to date is a 2019 meta-analysis by Koch and colleagues examining 41 studies of dance and DMT across multiple health outcomes. It found significant positive effects on depression (effect size d = 0.67), anxiety (d = 0.48), and quality of life (d = 0.38) compared to control conditions. Subgroup analyses suggested group DMT formats produced larger effects, particularly for social and relational outcomes.

The Cochrane Review for Depression

The 2019 Cochrane review by Karkou and colleagues — focused specifically on DMT for depression — examined five RCTs and found DMT significantly reduced depressive symptoms and improved quality of life compared to standard care. The review rated evidence quality as low to moderate and called for larger, more methodologically rigorous trials.

DMT in Other Conditions

For schizophrenia and psychosis, DMT has been studied primarily in inpatient settings, with positive effects on negative symptoms — the social withdrawal, flattened affect, and reduced motivation that medication often fails to address. A Cochrane review found insufficient evidence to draw firm conclusions but noted promising signals.

In dementia, DMT and adapted dance programmes show positive effects on agitation, mood, and social engagement. Studies by Hackney and colleagues on Parkinson's disease demonstrated that tango-based dance improved gait, balance, and quality of life compared to conventional exercise — one of the more compelling neurological applications of movement-based intervention.

In cancer care, a Cochrane review by Bradt and colleagues found DMT improved psychological wellbeing and body image in cancer patients, though study quality was again limited.

Structural Challenges in DMT Research

DMT research faces several inherent challenges: difficulty designing credible control conditions, heterogeneity of interventions across practitioners, small sample sizes driven by resource constraints, researcher allegiance effects, and the challenge of capturing meaningful outcomes with standardised instruments. These are not unique to DMT — they affect much of the arts therapies and psychotherapy research base — but they mean that the overall evidence level will remain lower than for more standardised interventions until larger, multi-site trials are conducted.

Evidence Context

moderate

The research base for DMT spans depression, anxiety, schizophrenia, dementia, and cancer care. Evidence quality is generally low to moderate due to structural challenges in arts therapies research. The overall direction is positive, with a 2019 meta-analysis finding significant effects across multiple mental health outcomes.

Safety & Considerations

DMT is delivered by qualified therapists trained to manage the psychological risks of embodied therapeutic work. It should be offered within appropriate clinical governance structures for clinical populations.

Who May Benefit

Researchers and clinicians seeking a summary of the DMT evidence landscape
People with mental health conditions researching evidence-based options
Those wanting to contextualise DMT within the broader arts therapies evidence base

Frequently Asked Questions

What conditions does the research cover for DMT?

The DMT research base is broadest for depression and anxiety, but also includes schizophrenia and psychosis, dementia, Parkinson's disease, cancer care, eating disorders, PTSD, and autism spectrum conditions. Evidence quality and quantity vary considerably across these areas.

Are dance therapists regulated in the UK?

Yes. Dance movement psychotherapists in the UK are registered with the Association for Dance Movement Psychotherapy UK (ADMP UK) and are typically required to hold a postgraduate qualification in DMT. The Health and Care Professions Council (HCPC) regulates arts therapists including dramatherapists, art therapists, and music therapists — DMT registration with HCPC is a separate ongoing regulatory development.

References

Written by

Gyfts Editorial Team

Editorial team at Gyfts researching holistic health modalities.

Reviewed by

Dr. Ava Gardner

Integrative Medicine Researcher

MB BCh BAO, MSc Integrative Medicine, MRCGP

Dr. Ava Gardner is a Dublin-based integrative medicine physician with over 15 years of clinical experience bridging conventional general practice and evidence-based complementary care. She holds a Masters in Integrative Medicine from the University of Arizona and has worked extensively in chronic pain management, women's hormonal health, and mind-body medicine. Dr. Gardner reviews health content for Gyfts to ensure clinical accuracy, balanced evidence presentation, and responsible safety guidance across modality and condition pages.

View full profile →